LivaNova (LIVN) Financials

$43.19 +0.02 (+0.05%)

Closing price 04:00 PM Eastern

Extended Trading

$43.24 +0.05 (+0.13%)

As of 04:21 PM Eastern

Annual Income Statements for LivaNova

This table shows LivaNova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	63	18	-86
Consolidated Net Income / (Loss)	63	18	-86
Net Income / (Loss) Continuing Operations	63	18	-86
Total Pre-Tax Income	88	-81	-75
Total Operating Income	129	-68	-77
Total Gross Profit	871	771	707
Total Revenue	1,253	1,154	1,022
Operating Revenue	1,253	1,154	1,022
Total Cost of Revenue	383	382	315
Operating Cost of Revenue	383	382	315
Total Operating Expenses	742	840	784
Selling, General & Admin Expense	526	518	469
Research & Development Expense	183	194	156
Other Operating Expenses / (Income)	33	38	30
Impairment Charge	0.00	90	129
Total Other Income / (Expense), net	-41	-13	1.61
Interest Expense	89	59	48
Other Income / (Expense), net	48	46	50
Income Tax Expense	25	-99	11
Other Gains / (Losses), net	-0.02	-0.10	-0.05
Basic Earnings per Share	$1.17	$0.33	($1.61)
Weighted Average Basic Shares Outstanding	54.24M	53.94M	53.47M
Diluted Earnings per Share	$1.16	$0.32	($1.61)
Weighted Average Diluted Shares Outstanding	54.57M	54.21M	53.47M
Weighted Average Basic & Diluted Shares Outstanding	54.35M	53.96M	53.56M

This table shows LivaNova's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-327	56	33	16	-42	16	-7.32	1.16	7.37	1.66	-107
Consolidated Net Income / (Loss)	-327	56	33	16	-42	16	-7.32	1.16	7.37	1.66	-107
Net Income / (Loss) Continuing Operations	-327	56	33	16	-42	16	-7.32	1.16	7.37	1.66	-107
Total Pre-Tax Income	-316	56	44	22	-34	-94	-1.98	5.28	9.77	6.39	-106
Total Operating Income	49	37	36	40	16	-88	4.46	17	-2.34	14	-132
Total Gross Profit	221	219	225	219	207	190	202	205	174	184	171
Total Revenue	317	322	318	319	295	310	286	294	263	275	253
Operating Revenue	317	322	318	319	295	310	286	294	263	275	253
Total Cost of Revenue	96	102	93	100	88	120	84	89	89	91	82
Operating Cost of Revenue	96	102	93	100	88	120	84	89	89	91	82
Total Operating Expenses	172	182	190	179	191	278	197	188	176	170	303
Selling, General & Admin Expense	134	136	132	129	130	133	135	126	124	120	115
Research & Development Expense	38	43	49	45	46	46	47	51	50	45	36
Other Operating Expenses / (Income)	0.61	3.40	9.18	4.84	16	8.68	16	11	2.31	5.02	23
Total Other Income / (Expense), net	-364	19	8.82	-19	-50	-6.31	-6.44	-12	12	-7.57	26
Interest Expense	15	16	16	16	41	16	15	15	13	13	13
Other Income / (Expense), net	-349	35	25	-3.05	-9.07	9.32	8.55	2.71	26	5.80	39
Income Tax Expense	12	0.59	12	5.23	7.72	-111	5.31	4.10	2.37	4.70	1.30
Other Gains / (Losses), net	-0.02	-	0.04	-0.03	-0.03	-0.02	-0.03	-0.03	-0.03	-0.03	0.06
Basic Earnings per Share	($6.01)	$1.04	$0.61	$0.30	($0.78)	$0.31	($0.14)	$0.02	$0.14	$0.03	($2.01)
Weighted Average Basic Shares Outstanding	54.42M	54.24M	54.35M	54.24M	54.01M	53.94M	53.99M	53.80M	53.62M	53.47M	53.53M
Diluted Earnings per Share	($6.01)	$1.04	$0.60	$0.30	($0.78)	$0.30	($0.14)	$0.02	$0.14	$0.04	($2.01)
Weighted Average Diluted Shares Outstanding	54.42M	54.57M	54.59M	54.59M	54.01M	54.21M	53.99M	53.98M	53.90M	53.47M	53.53M
Weighted Average Basic & Diluted Shares Outstanding	54.53M	54.35M	54.30M	54.30M	54.15M	53.96M	53.87M	53.88M	53.77M	53.56M	53.52M

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	146	62	308
Net Cash From Operating Activities	183	75	70
Net Cash From Continuing Operating Activities	184	75	70
Net Income / (Loss) Continuing Operations	63	18	-86
Consolidated Net Income / (Loss)	63	18	-86
Depreciation Expense	42	50	48
Amortization Expense	30	30	32
Non-Cash Adjustments To Reconcile Net Income	62	140	176
Changes in Operating Assets and Liabilities, net	-14	-163	-99
Net Cash From Investing Activities	-48	-40	-38
Net Cash From Continuing Investing Activities	-48	-40	-38
Purchase of Property, Plant & Equipment	-47	-35	-27
Acquisitions	0.00	0.00	-8.86
Purchase of Investments	-1.14	-6.50	-2.95
Other Investing Activities, net	0.09	1.15	-0.09
Net Cash From Financing Activities	19	21	280
Net Cash From Continuing Financing Activities	19	21	280
Repayment of Debt	-318	-21	-221
Repurchase of Common Equity	-5.94	0.00	-3.29
Issuance of Debt	336	50	508
Other Financing Activities, net	6.68	-7.48	-3.43
Effect of Exchange Rate Changes	-7.75	6.19	-4.01
Cash Interest Paid	39	37	19
Cash Income Taxes Paid	16	-1.62	1.22

This table details how cash moves in and out of LivaNova's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	15	57	33	17	38	45	-1.64	11	7.34	9.34	100
Net Cash From Operating Activities	24	79	51	43	9.98	54	18	-18	21	19	36
Net Cash From Continuing Operating Activities	24	80	51	43	9.98	54	18	-18	21	19	36
Net Income / (Loss) Continuing Operations	-327	56	33	16	-42	16	-7.32	1.16	7.37	1.66	-107
Consolidated Net Income / (Loss)	-327	56	33	16	-42	16	-7.32	1.16	7.37	1.66	-107
Depreciation Expense	6.42	11	11	10	11	12	13	12	12	12	12
Amortization Expense	14	7.82	8.04	7.13	7.44	8.18	6.87	6.98	7.66	8.07	6.83
Non-Cash Adjustments To Reconcile Net Income	373	2.28	-2.74	16	47	137	12	6.88	-16	51	106
Changes in Operating Assets and Liabilities, net	-42	3.42	2.16	-6.62	-13	-120	-6.22	-45	9.23	-54	19
Net Cash From Investing Activities	-11	-11	-19	-13	-6.36	-12	-10	-6.66	-11	-11	-5.83
Net Cash From Continuing Investing Activities	-11	-11	-19	-13	-6.36	-12	-10	-6.66	-11	-11	-5.83
Purchase of Property, Plant & Equipment	-11	-10	-18	-12	-6.40	-13	-8.72	-5.66	-7.69	-9.13	-6.04
Other Investing Activities, net	0.16	-0.01	0.10	-0.04	0.04	0.72	-0.18	-0.72	1.34	0.21	0.36
Net Cash From Financing Activities	-4.42	-3.44	-3.28	-12	37	-5.02	-4.28	36	-5.24	-1.66	73
Net Cash From Continuing Financing Activities	-4.42	-3.44	-3.28	-12	37	-5.02	-4.28	36	-5.24	-1.66	73
Repayment of Debt	-4.42	-4.38	-4.45	-3.94	-305	-4.51	-3.13	-9.74	-3.66	2.90	-220
Issuance of Debt	0.00	-	-	-	336	-	-	50	0.00	-	289
Other Financing Activities, net	0.00	0.95	1.40	-4.13	8.46	-0.51	-1.15	-4.25	-1.58	-8.03	-
Effect of Exchange Rate Changes	5.96	-7.58	4.26	-1.48	-2.95	8.35	-5.44	-0.02	3.30	3.25	-3.53

This table presents LivaNova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	2,506	2,430	2,295
Total Current Assets	1,127	988	886
Cash & Equivalents	429	267	214
Restricted Cash	295	311	301
Accounts Receivable	193	215	183
Inventories, net	148	148	129
Prepaid Expenses	32	27	26
Current Deferred & Refundable Income Taxes	31	20	32
Plant, Property, & Equipment, net	170	154	147
Total Noncurrent Assets	1,209	1,287	1,261
Goodwill	750	783	769
Intangible Assets	237	261	369
Noncurrent Deferred & Refundable Income Taxes	112	119	1.38
Other Noncurrent Operating Assets	110	124	123
Total Liabilities & Shareholders' Equity	2,506	2,430	2,295
Total Liabilities	1,186	1,152	1,087
Total Current Liabilities	392	335	297
Short-Term Debt	78	18	23
Accounts Payable	70	81	74
Accrued Expenses	118	107	81
Current Deferred & Payable Income Tax Liabilities	32	23	17
Current Employee Benefit Liabilities	81	95	72
Other Current Liabilities	13	11	29
Total Noncurrent Liabilities	794	817	790
Long-Term Debt	550	569	518
Noncurrent Deferred & Payable Income Tax Liabilities	11	12	8.52
Noncurrent Employee Benefit Liabilities	13	17	17
Other Noncurrent Operating Liabilities	221	220	246
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,320	1,278	1,208
Total Preferred & Common Equity	1,320	1,278	1,208
Total Common Equity	1,320	1,278	1,208
Common Stock	2,304	2,272	2,240
Retained Earnings	-903	-966	-984
Treasury Stock	-0.14	-0.06	-0.38
Accumulated Other Comprehensive Income / (Loss)	-80	-28	-48

This table presents LivaNova's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	2,559	2,522	2,453	2,460	2,329	2,342	2,295	2,213
Total Current Assets	1,171	1,093	1,047	1,040	954	942	903	851
Cash & Equivalents	738	346	329	309	234	223	214	231
Restricted Cash	0.00	320	304	306	299	311	309	275
Accounts Receivable	202	197	201	209	190	186	178	172
Inventories, net	154	162	155	153	162	156	142	122
Prepaid Expenses	47	43	36	39	44	39	35	24
Current Deferred & Refundable Income Taxes	29	24	22	23	26	26	24	26
Plant, Property, & Equipment, net	178	169	158	152	149	150	149	139
Total Noncurrent Assets	1,210	1,260	1,248	1,267	1,226	1,250	1,243	1,222
Goodwill	762	782	766	772	767	779	774	742
Intangible Assets	237	249	248	254	348	357	364	365
Noncurrent Deferred & Refundable Income Taxes	109	110	113	114	1.51	2.11	1.53	1.42
Other Noncurrent Operating Assets	102	119	121	128	110	111	103	114
Total Liabilities & Shareholders' Equity	2,559	2,522	2,453	2,460	2,329	2,342	2,295	2,213
Total Liabilities	1,524	1,212	1,211	1,238	1,104	1,101	1,068	1,066
Total Current Liabilities	742	324	303	328	295	288	316	288
Short-Term Debt	80	22	20	20	19	19	22	22
Accounts Payable	88	78	81	76	63	78	76	70
Accrued Expenses	469	105	98	94	90	82	96	79
Current Deferred & Payable Income Tax Liabilities	40	27	23	30	22	20	22	12
Current Employee Benefit Liabilities	53	77	65	91	75	67	80	58
Other Current Liabilities	13	16	16	17	27	22	19	48
Total Noncurrent Liabilities	783	888	908	910	809	813	751	778
Long-Term Debt	549	604	605	605	568	568	520	518
Noncurrent Deferred & Payable Income Tax Liabilities	11	12	11	11	9.93	8.92	8.63	6.53
Noncurrent Employee Benefit Liabilities	13	15	16	17	16	17	16	18
Other Noncurrent Operating Liabilities	210	257	275	278	215	219	206	236
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,034	1,310	1,243	1,222	1,225	1,241	1,227	1,147
Total Preferred & Common Equity	1,034	1,310	1,243	1,222	1,225	1,241	1,227	1,147
Total Common Equity	1,034	1,310	1,243	1,222	1,225	1,241	1,227	1,147
Common Stock	2,309	2,296	2,288	2,276	2,263	2,252	2,245	2,226
Retained Earnings	-1,231	-959	-992	-1,008	-983	-976	-977	-986
Treasury Stock	-1.43	-0.16	-0.20	-0.48	-0.06	-0.10	-0.32	-0.38
Accumulated Other Comprehensive Income / (Loss)	-43	-27	-53	-45	-55	-36	-41	-93

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	8.66%	12.89%	-1.31%
EBITDA Growth	333.82%	10.14%	-25.97%
EBIT Growth	890.52%	16.80%	-90.95%
NOPAT Growth	292.77%	10.75%	-9,689.80%
Net Income Growth	260.39%	120.34%	36.50%
EPS Growth	262.50%	119.88%	39.93%
Operating Cash Flow Growth	144.33%	7.14%	-31.81%
Free Cash Flow Firm Growth	253.21%	-358.98%	-73.05%
Invested Capital Growth	-4.83%	4.29%	-6.99%
Revenue Q/Q Growth	0.94%	3.15%	0.47%
EBITDA Q/Q Growth	147.44%	-62.97%	39.74%
EBIT Q/Q Growth	581.81%	-129.42%	36.88%
NOPAT Q/Q Growth	3,168.48%	-1,034.95%	-16.37%
Net Income Q/Q Growth	167.01%	511.79%	7.30%
EPS Q/Q Growth	176.19%	433.33%	5.85%
Operating Cash Flow Q/Q Growth	15.64%	88.90%	-17.45%
Free Cash Flow Firm Q/Q Growth	1,082.92%	-7.08%	-72.66%
Invested Capital Q/Q Growth	-3.57%	0.51%	4.48%
Profitability Metrics	-	-	-
Gross Margin	69.48%	66.86%	69.21%
EBITDA Margin	19.91%	4.99%	5.11%
Operating Margin	10.30%	-5.94%	-7.51%
EBIT Margin	14.11%	-1.94%	-2.63%
Profit (Net Income) Margin	5.04%	1.52%	-8.44%
Tax Burden Percent	71.60%	-21.60%	114.78%
Interest Burden Percent	49.93%	363.05%	279.42%
Effective Tax Rate	28.38%	0.00%	0.00%
Return on Invested Capital (ROIC)	7.36%	-3.81%	-4.20%
ROIC Less NNEP Spread (ROIC-NNEP)	74.37%	374.07%	-117.48%
Return on Net Nonoperating Assets (RNNOA)	-2.49%	5.22%	-2.70%
Return on Equity (ROE)	4.87%	1.41%	-6.89%
Cash Return on Invested Capital (CROIC)	12.31%	-8.00%	3.04%
Operating Return on Assets (OROA)	7.17%	-0.95%	-1.20%
Return on Assets (ROA)	2.56%	0.74%	-3.84%
Return on Common Equity (ROCE)	4.87%	1.41%	-6.89%
Return on Equity Simple (ROE_SIMPLE)	4.79%	1.37%	-7.14%
Net Operating Profit after Tax (NOPAT)	92	-48	-54
NOPAT Margin	7.37%	-4.16%	-5.26%
Net Nonoperating Expense Percent (NNEP)	-67.01%	-377.87%	113.28%
Return On Investment Capital (ROIC_SIMPLE)	4.75%	-2.57%	-3.07%
Cost of Revenue to Revenue	30.52%	33.14%	30.79%
SG&A Expenses to Revenue	41.99%	44.92%	45.92%
R&D to Revenue	14.56%	16.80%	15.25%
Operating Expenses to Revenue	59.18%	72.80%	76.73%
Earnings before Interest and Taxes (EBIT)	177	-22	-27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	250	58	52
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.90	2.18	2.46
Price to Tangible Book Value (P/TBV)	7.55	11.94	42.30
Price to Revenue (P/Rev)	2.01	2.42	2.91
Price to Earnings (P/E)	39.77	158.86	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	2.51%	0.63%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.98	2.17	2.43
Enterprise Value to Revenue (EV/Rev)	1.93	2.42	2.93
Enterprise Value to EBITDA (EV/EBITDA)	9.69	48.60	57.40
Enterprise Value to EBIT (EV/EBIT)	13.68	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	26.17	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.21	37.32	42.88
Enterprise Value to Free Cash Flow (EV/FCFF)	15.65	0.00	77.00
Leverage & Solvency	-	-	-
Debt to Equity	0.48	0.46	0.45
Long-Term Debt to Equity	0.42	0.45	0.43
Financial Leverage	-0.03	0.01	0.02
Leverage Ratio	1.90	1.90	1.80
Compound Leverage Factor	0.95	6.90	5.02
Debt to Total Capital	32.22%	31.47%	30.96%
Short-Term Debt to Total Capital	4.00%	0.97%	1.34%
Long-Term Debt to Total Capital	28.22%	30.50%	29.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.78%	68.53%	69.04%
Debt to EBITDA	2.51	10.20	10.37
Net Debt to EBITDA	-0.38	0.15	0.50
Long-Term Debt to EBITDA	2.20	9.88	9.92
Debt to NOPAT	6.79	-12.24	-10.08
Net Debt to NOPAT	-1.04	-0.18	-0.48
Long-Term Debt to NOPAT	5.95	-11.86	-9.64
Altman Z-Score	1.85	1.66	1.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.87	2.95	2.98
Quick Ratio	1.59	1.44	1.34
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	155	-101	39
Operating Cash Flow to CapEx	388.56%	214.16%	263.68%
Free Cash Flow to Firm to Interest Expense	1.74	-1.71	0.81
Operating Cash Flow to Interest Expense	2.07	1.27	1.45
Operating Cash Flow Less CapEx to Interest Expense	1.54	0.68	0.90
Efficiency Ratios	-	-	-
Asset Turnover	0.51	0.49	0.45
Accounts Receivable Turnover	6.14	5.79	5.55
Inventory Turnover	2.59	2.76	2.67
Fixed Asset Turnover	7.73	7.66	6.88
Accounts Payable Turnover	5.08	4.93	4.42
Days Sales Outstanding (DSO)	59.44	63.00	65.81
Days Inventory Outstanding (DIO)	140.94	132.36	136.46
Days Payable Outstanding (DPO)	71.83	74.07	82.56
Cash Conversion Cycle (CCC)	128.55	121.29	119.71
Capital & Investment Metrics	-	-	-
Invested Capital	1,224	1,286	1,234
Invested Capital Turnover	1.00	0.92	0.80
Increase / (Decrease) in Invested Capital	-62	53	-93
Enterprise Value (EV)	2,419	2,796	2,999
Market Capitalization	2,515	2,787	2,973
Book Value per Share	$24.31	$23.72	$22.56
Tangible Book Value per Share	$6.13	$4.33	$1.31
Total Capital	1,948	1,864	1,749
Total Debt	628	587	542
Total Long-Term Debt	550	569	518
Net Debt	-96	8.78	26
Capital Expenditures (CapEx)	47	35	27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	90	93	97
Debt-free Net Working Capital (DFNWC)	813	671	612
Net Working Capital (NWC)	735	653	589
Net Nonoperating Expense (NNE)	29	-65	33
Net Nonoperating Obligations (NNO)	-96	8.78	26
Total Depreciation and Amortization (D&A)	73	80	79
Debt-free, Cash-free Net Working Capital to Revenue	7.14%	8.10%	9.45%
Debt-free Net Working Capital to Revenue	64.87%	58.19%	59.91%
Net Working Capital to Revenue	58.64%	56.62%	57.62%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$1.17	$0.33	($1.61)
Adjusted Weighted Average Basic Shares Outstanding	54.24M	53.94M	53.47M
Adjusted Diluted Earnings per Share	$1.16	$0.32	($1.61)
Adjusted Weighted Average Diluted Shares Outstanding	54.57M	54.21M	53.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.35M	53.96M	53.56M
Normalized Net Operating Profit after Tax (NOPAT)	92	15	37
Normalized NOPAT Margin	7.37%	1.30%	3.61%
Pre Tax Income Margin	7.05%	-7.04%	-7.35%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	2.00	-0.38	-0.56
NOPAT to Interest Expense	1.04	-0.81	-1.11
EBIT Less CapEx to Interest Expense	1.47	-0.97	-1.11
NOPAT Less CapEx to Interest Expense	0.51	-1.41	-1.66
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	9.39%	0.00%	-3.82%

This table displays calculated financial ratios and metrics derived from LivaNova's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.44%	3.77%	11.19%	8.40%	11.96%	12.83%	13.27%	15.63%	9.68%	1.78%	-0.24%
EBITDA Growth	-1,210.55%	256.46%	140.64%	38.35%	-41.60%	-245.61%	143.71%	-27.98%	32.59%	59.49%	-249.50%
EBIT Growth	-4,286.20%	191.83%	363.71%	84.78%	-69.08%	-498.25%	113.92%	-39.83%	73.06%	388.38%	-411.11%
NOPAT Growth	199.26%	159.48%	745.39%	681.92%	741.22%	-1,769.29%	103.38%	-85.87%	-134.27%	-78.71%	-903.64%
Net Income Growth	-680.40%	242.07%	550.30%	1,314.11%	-669.10%	883.68%	93.18%	-92.98%	146.24%	132.40%	-147.09%
EPS Growth	-670.51%	246.67%	528.57%	1,400.00%	-657.14%	650.00%	93.03%	-93.33%	133.33%	166.67%	-139.29%
Operating Cash Flow Growth	140.12%	45.87%	181.18%	341.71%	-51.92%	188.50%	-49.11%	-75.11%	-19.62%	-44.14%	48.78%
Free Cash Flow Firm Growth	1,115.68%	186.22%	138.06%	71.76%	-54.47%	-218.82%	-199.98%	103.95%	-11.40%	-40.65%	-76.89%
Invested Capital Growth	-24.84%	-4.83%	-0.80%	-4.54%	-1.33%	4.29%	8.41%	-3.58%	-4.82%	-6.99%	-13.77%
Revenue Q/Q Growth	-1.55%	1.17%	-0.14%	8.02%	-4.91%	8.39%	-2.64%	11.56%	-4.17%	8.82%	-0.61%
EBITDA Q/Q Growth	-408.60%	14.94%	44.30%	116.98%	143.48%	-276.78%	-17.04%	-8.41%	8.41%	153.06%	-236.71%
EBIT Q/Q Growth	-515.74%	19.77%	62.49%	417.37%	109.12%	-704.82%	-35.25%	-13.43%	17.46%	121.14%	-379.87%
NOPAT Q/Q Growth	-7.11%	38.87%	-13.34%	167.68%	118.46%	-2,073.76%	-19.84%	319.51%	-148.07%	103.99%	-435.29%
Net Income Q/Q Growth	-685.64%	69.61%	101.76%	138.94%	-356.70%	323.27%	-733.59%	-84.33%	343.71%	101.55%	-752.79%
EPS Q/Q Growth	-677.88%	73.33%	100.00%	138.46%	-360.00%	314.29%	-800.00%	-85.71%	250.00%	101.99%	-770.00%
Operating Cash Flow Q/Q Growth	-69.55%	54.35%	17.62%	334.39%	-81.50%	197.52%	201.11%	-186.41%	10.98%	-47.52%	447.93%
Free Cash Flow Firm Q/Q Growth	244.11%	169.60%	-58.91%	218.94%	124.40%	-19.03%	-285.39%	-15.46%	-36.30%	0.15%	107.32%
Invested Capital Q/Q Growth	-24.48%	-3.57%	2.84%	0.35%	-4.36%	0.51%	-1.03%	3.72%	1.08%	4.48%	-11.98%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.68%	68.16%	70.81%	68.70%	70.32%	61.32%	70.53%	69.82%	66.09%	66.76%	67.66%
EBITDA Margin	-88.37%	28.19%	24.82%	17.17%	8.55%	-18.70%	11.47%	13.46%	16.39%	14.49%	-29.71%
Operating Margin	15.34%	11.50%	11.20%	12.61%	5.51%	-28.37%	1.56%	5.91%	-0.89%	5.08%	-52.24%
EBIT Margin	-94.79%	22.45%	18.96%	11.65%	2.43%	-25.37%	4.55%	6.84%	8.81%	7.19%	-36.99%
Profit (Net Income) Margin	-103.30%	17.37%	10.36%	5.13%	-14.22%	5.27%	-2.56%	0.39%	2.80%	0.60%	-42.49%
Tax Burden Percent	103.70%	98.96%	74.15%	75.65%	122.64%	-17.33%	369.97%	21.88%	75.45%	25.98%	101.17%
Interest Burden Percent	105.09%	78.18%	73.68%	58.16%	-476.66%	119.86%	-15.21%	26.28%	42.09%	32.37%	113.55%
Effective Tax Rate	0.00%	1.04%	25.93%	24.21%	0.00%	0.00%	0.00%	77.59%	24.27%	73.57%	0.00%
Return on Invested Capital (ROIC)	12.71%	11.37%	8.08%	9.15%	3.69%	-18.18%	0.99%	1.09%	-0.55%	1.07%	-29.17%
ROIC Less NNEP Spread (ROIC-NNEP)	729.19%	-32.83%	101.10%	-53.95%	-372.91%	431.45%	-22.70%	-3.80%	47.93%	-6.00%	-62.28%
Return on Net Nonoperating Assets (RNNOA)	-32.61%	1.10%	0.56%	-0.97%	-4.31%	6.02%	-0.84%	-0.17%	0.72%	-0.14%	-2.29%
Return on Equity (ROE)	-19.89%	12.47%	8.64%	8.17%	-0.62%	-12.17%	0.15%	0.92%	0.17%	0.93%	-31.46%
Cash Return on Invested Capital (CROIC)	38.85%	12.31%	1.02%	3.14%	-1.48%	-8.00%	-7.66%	-1.83%	0.09%	3.04%	11.17%
Operating Return on Assets (OROA)	-48.18%	11.40%	9.71%	5.88%	1.21%	-12.39%	2.24%	3.17%	3.91%	3.27%	-17.04%
Return on Assets (ROA)	-52.51%	8.82%	5.30%	2.59%	-7.09%	2.57%	-1.26%	0.18%	1.24%	0.27%	-19.57%
Return on Common Equity (ROCE)	-19.89%	12.47%	8.64%	8.17%	-0.62%	-12.17%	0.15%	0.92%	0.17%	0.93%	-31.46%
Return on Equity Simple (ROE_SIMPLE)	-21.48%	0.00%	1.81%	-1.34%	-2.60%	0.00%	0.23%	-7.83%	-6.67%	0.00%	-8.11%
Net Operating Profit after Tax (NOPAT)	34	37	26	30	11	-62	3.12	3.89	-1.77	3.69	-92
NOPAT Margin	10.74%	11.38%	8.29%	9.56%	3.86%	-19.86%	1.09%	1.32%	-0.67%	1.34%	-36.57%
Net Nonoperating Expense Percent (NNEP)	-716.47%	44.19%	-93.02%	63.10%	376.60%	-449.63%	23.69%	4.89%	-48.48%	7.07%	33.11%
Return On Investment Capital (ROIC_SIMPLE)	2.05%	1.88%	-	-	-	-3.30%	-	-	-	0.21%	-
Cost of Revenue to Revenue	30.32%	31.84%	29.19%	31.30%	29.68%	38.68%	29.47%	30.18%	33.91%	33.24%	32.34%
SG&A Expenses to Revenue	42.19%	42.14%	41.39%	40.53%	44.03%	42.99%	47.11%	42.83%	47.12%	43.51%	45.38%
R&D to Revenue	11.95%	13.46%	15.34%	14.04%	15.48%	14.89%	16.27%	17.40%	18.98%	16.35%	14.14%
Operating Expenses to Revenue	54.33%	56.66%	59.61%	56.09%	64.81%	89.69%	68.97%	63.91%	66.98%	61.69%	119.91%
Earnings before Interest and Taxes (EBIT)	-300	72	60	37	7.18	-79	13	20	23	20	-93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-280	91	79	55	25	-58	33	40	43	40	-75
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.06	1.90	2.18	2.39	2.47	2.18	2.33	2.23	1.90	2.46	2.37
Price to Tangible Book Value (P/TBV)	59.65	7.55	10.19	13.02	15.42	11.94	25.73	26.60	26.28	42.30	68.71
Price to Revenue (P/Rev)	1.67	2.01	2.30	2.45	2.55	2.42	2.55	2.55	2.23	2.91	2.67
Price to Earnings (P/E)	0.00	39.77	120.46	0.00	0.00	158.86	993.49	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	2.51%	0.83%	0.00%	0.00%	0.63%	0.10%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.19	1.98	2.22	2.40	2.46	2.17	2.27	2.18	1.89	2.43	2.33
Enterprise Value to Revenue (EV/Rev)	1.59	1.93	2.27	2.45	2.55	2.42	2.60	2.60	2.25	2.93	2.71
Enterprise Value to EBITDA (EV/EBITDA)	0.00	9.69	27.88	54.09	76.49	48.60	18.69	59.34	37.45	57.40	73.62
Enterprise Value to EBIT (EV/EBIT)	0.00	13.68	108.42	0.00	0.00	0.00	38.18	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	17.92	26.17	994.51	0.00	0.00	0.00	566.21	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	10.28	13.21	17.77	23.60	47.20	37.32	73.22	49.30	36.29	42.88	32.49
Enterprise Value to Free Cash Flow (EV/FCFF)	4.84	15.65	215.32	74.59	0.00	0.00	0.00	0.00	2,079.96	77.00	19.32
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.61	0.48	0.48	0.50	0.51	0.46	0.48	0.47	0.44	0.45	0.47
Long-Term Debt to Equity	0.53	0.42	0.46	0.49	0.50	0.45	0.46	0.46	0.42	0.43	0.45
Financial Leverage	-0.04	-0.03	0.01	0.02	0.01	0.01	0.04	0.04	0.02	0.02	0.04
Leverage Ratio	2.22	1.90	1.91	1.93	1.94	1.90	1.91	1.85	1.87	1.80	1.80
Compound Leverage Factor	2.34	1.49	1.41	1.12	-9.25	2.28	-0.29	0.49	0.79	0.58	2.04
Debt to Total Capital	37.81%	32.22%	32.34%	33.47%	33.83%	31.47%	32.39%	32.12%	30.65%	30.96%	32.01%
Short-Term Debt to Total Capital	4.78%	4.00%	1.13%	1.06%	1.07%	0.97%	1.05%	1.04%	1.26%	1.34%	1.29%
Long-Term Debt to Total Capital	33.02%	28.22%	31.21%	32.42%	32.76%	30.50%	31.34%	31.08%	29.39%	29.62%	30.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.19%	67.78%	67.66%	66.53%	66.17%	68.53%	67.61%	67.88%	69.35%	69.04%	67.99%
Debt to EBITDA	-11.30	2.51	6.21	11.42	15.78	10.20	3.78	12.36	8.63	10.37	14.44
Net Debt to EBITDA	1.97	-0.38	-0.40	-0.15	0.22	0.15	0.35	1.11	0.31	0.50	0.90
Long-Term Debt to EBITDA	-9.87	2.20	5.99	11.06	15.28	9.88	3.66	11.96	8.28	9.92	13.86
Debt to NOPAT	5.56	6.79	221.44	-32.93	-17.87	-12.24	114.50	-8.14	-8.75	-10.08	-11.69
Net Debt to NOPAT	-0.97	-1.04	-14.26	0.42	-0.25	-0.18	10.62	-0.73	-0.32	-0.48	-0.73
Long-Term Debt to NOPAT	4.86	5.95	213.68	-31.89	-17.31	-11.86	110.79	-7.88	-8.39	-9.64	-11.22
Altman Z-Score	0.48	1.71	1.82	1.81	1.73	1.59	1.80	1.75	1.51	1.82	1.53
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.58	2.87	3.37	3.45	3.17	2.95	3.23	3.27	2.86	2.98	2.96
Quick Ratio	1.27	1.59	1.68	1.75	1.58	1.44	1.43	1.42	1.24	1.34	1.40
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	340	99	37	89	28	-114	-96	52	61	96	96
Operating Cash Flow to CapEx	222.11%	756.36%	281.01%	356.66%	156.00%	417.66%	208.03%	-316.96%	270.10%	204.76%	589.94%
Free Cash Flow to Firm to Interest Expense	22.22	6.26	2.31	5.74	0.68	-7.33	-6.42	3.50	4.57	7.21	7.60
Operating Cash Flow to Interest Expense	1.57	4.99	3.21	2.79	0.24	3.45	1.21	-1.21	1.54	1.40	2.81
Operating Cash Flow Less CapEx to Interest Expense	0.86	4.33	2.07	2.01	0.09	2.63	0.63	-1.59	0.97	0.72	2.34
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.51	0.51	0.51	0.50	0.50	0.49	0.49	0.46	0.44	0.45	0.46
Accounts Receivable Turnover	6.20	6.14	6.42	6.26	6.11	5.79	6.18	5.98	5.80	5.55	5.74
Inventory Turnover	2.55	2.59	2.47	2.52	2.57	2.76	2.49	2.55	2.58	2.67	2.37
Fixed Asset Turnover	7.73	7.73	7.79	7.87	7.87	7.66	7.75	7.41	7.04	6.88	6.97
Accounts Payable Turnover	4.78	5.08	5.69	4.91	5.02	4.93	5.34	4.60	4.44	4.42	4.49
Days Sales Outstanding (DSO)	58.89	59.44	56.88	58.35	59.71	63.00	59.07	61.04	62.94	65.81	63.54
Days Inventory Outstanding (DIO)	143.34	140.94	147.72	145.05	141.80	132.36	146.33	143.41	141.36	136.46	153.80
Days Payable Outstanding (DPO)	76.33	71.83	64.17	74.37	72.75	74.07	68.32	79.31	82.22	82.56	81.26
Cash Conversion Cycle (CCC)	125.89	128.55	140.42	129.03	128.76	121.29	137.08	125.14	122.08	119.71	136.08
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	925	1,224	1,270	1,235	1,230	1,286	1,280	1,293	1,247	1,234	1,181
Invested Capital Turnover	1.18	1.00	0.97	0.96	0.96	0.92	0.91	0.82	0.82	0.80	0.80
Increase / (Decrease) in Invested Capital	-306	-62	-10	-59	-17	53	99	-48	-63	-93	-189
Enterprise Value (EV)	2,025	2,419	2,812	2,961	3,027	2,796	2,904	2,818	2,354	2,999	2,752
Market Capitalization	2,135	2,515	2,853	2,969	3,018	2,787	2,849	2,765	2,334	2,973	2,719
Book Value per Share	$19.03	$24.31	$24.13	$22.95	$22.64	$23.72	$22.74	$23.07	$22.91	$22.56	$21.42
Tangible Book Value per Share	$0.66	$6.13	$5.16	$4.21	$3.63	$4.33	$2.06	$1.93	$1.66	$1.31	$0.74
Total Capital	1,663	1,948	1,936	1,868	1,846	1,864	1,813	1,828	1,770	1,749	1,687
Total Debt	629	628	626	625	624	587	587	587	542	542	540
Total Long-Term Debt	549	550	604	605	605	569	568	568	520	518	518
Net Debt	-110	-96	-40	-7.95	8.77	8.78	54	53	20	26	34
Capital Expenditures (CapEx)	11	10	18	12	6.40	13	8.72	5.66	7.69	9.13	6.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-229	90	124	130	116	93	145	138	86	97	79
Debt-free Net Working Capital (DFNWC)	509	813	791	763	732	671	677	673	609	612	585
Net Working Capital (NWC)	430	735	769	744	712	653	658	654	587	589	563
Net Nonoperating Expense (NNE)	361	-19	-6.57	14	53	-78	10	2.74	-9.14	2.03	15
Net Nonoperating Obligations (NNO)	-110	-96	-40	-7.95	8.77	8.78	54	53	20	26	34
Total Depreciation and Amortization (D&A)	20	18	19	18	18	21	20	19	20	20	18
Debt-free, Cash-free Net Working Capital to Revenue	-17.98%	7.14%	9.99%	10.77%	9.81%	8.10%	12.95%	12.76%	8.25%	9.45%	7.73%
Debt-free Net Working Capital to Revenue	39.92%	64.87%	63.67%	63.11%	61.77%	58.19%	60.58%	62.02%	58.29%	59.91%	57.51%
Net Working Capital to Revenue	33.68%	58.64%	61.91%	61.48%	60.10%	56.62%	58.88%	60.26%	56.16%	57.62%	55.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($6.01)	$1.04	$0.61	$0.30	($0.78)	$0.31	($0.14)	$0.02	$0.14	$0.03	($2.01)
Adjusted Weighted Average Basic Shares Outstanding	54.42M	54.24M	54.35M	54.24M	54.01M	53.94M	53.99M	53.80M	53.62M	53.47M	53.53M
Adjusted Diluted Earnings per Share	($6.01)	$1.04	$0.60	$0.30	($0.78)	$0.30	($0.14)	$0.02	$0.14	$0.04	($2.01)
Adjusted Weighted Average Diluted Shares Outstanding	54.42M	54.57M	54.59M	54.59M	54.01M	54.21M	53.99M	53.98M	53.90M	53.47M	53.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.53M	54.35M	54.30M	54.30M	54.15M	53.96M	53.87M	53.88M	53.77M	53.56M	53.52M
Normalized Net Operating Profit after Tax (NOPAT)	34	37	26	30	11	-62	3.12	12	-1.77	9.77	-1.80
Normalized NOPAT Margin	10.74%	11.38%	8.29%	9.56%	3.86%	-19.86%	1.09%	4.14%	-0.67%	3.56%	-0.71%
Pre Tax Income Margin	-99.62%	17.55%	13.97%	6.78%	-11.60%	-30.41%	-0.69%	1.80%	3.71%	2.33%	-42.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-19.65	4.58	3.80	2.39	0.17	-5.04	0.87	1.36	1.73	1.48	-7.38
NOPAT to Interest Expense	2.23	2.32	1.66	1.96	0.27	-3.94	0.21	0.26	-0.13	0.28	-7.30
EBIT Less CapEx to Interest Expense	-20.36	3.92	2.66	1.61	0.02	-5.86	0.29	0.97	1.16	0.79	-7.86
NOPAT Less CapEx to Interest Expense	1.52	1.66	0.52	1.18	0.12	-4.77	-0.37	-0.12	-0.70	-0.41	-7.77
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	9.39%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-3.82%	0.00%

Frequently Asked Questions About LivaNova's Financials

When does LivaNova's fiscal year end?

According to the most recent income statement we have on file, LivaNova's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has LivaNova's net income changed over the last 2 years?

LivaNova's net income appears to be on a downward trend, with a most recent value of $63.23 million in 2024, falling from -$86.25 million in 2022. The previous period was $17.55 million in 2023. See LivaNova's forecast for analyst expectations on what’s next for the company.

What is LivaNova's operating income?

LivaNova's total operating income in 2024 was $129.05 million, based on the following breakdown:

Total Gross Profit: $870.87 million
Total Operating Expenses: $741.82 million

How has LivaNova revenue changed over the last 2 years?

Over the last 2 years, LivaNova's total revenue changed from $1.02 billion in 2022 to $1.25 billion in 2024, a change of 22.7%.

How much debt does LivaNova have?

LivaNova's total liabilities were at $1.19 billion at the end of 2024, a 3.0% increase from 2023, and a 9.1% increase since 2022.

How much cash does LivaNova have?

In the past 2 years, LivaNova's cash and equivalents has ranged from $214.17 million in 2022 to $428.86 million in 2024, and is currently $428.86 million as of their latest financial filing in 2024.

How has LivaNova's book value per share changed over the last 2 years?

Over the last 2 years, LivaNova's book value per share changed from 22.56 in 2022 to 24.31 in 2024, a change of 7.8%.

Related Companies

This page (NASDAQ:LIVN) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LivaNova (LIVN) Financials

Frequently Asked Questions About LivaNova's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LivaNova (LIVN) Financials

Annual Income Statements for LivaNova

Quarterly Income Statements for LivaNova

Annual Cash Flow Statements for LivaNova

Quarterly Cash Flow Statements for LivaNova

Annual Balance Sheets for LivaNova

Quarterly Balance Sheets for LivaNova

Annual Metrics And Ratios for LivaNova

Quarterly Metrics And Ratios for LivaNova

Frequently Asked Questions About LivaNova's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools